| Literature DB >> 24830711 |
Juliano S de Toledo1, Sergio R Ambrósio2, Carly H G Borges3, Viviane Manfrim4, Daniel G Cerri5, Angela K Cruz6, Fernando B Da Costa7.
Abstract
Natural compounds represent a rich and promising source of novel, biologically active chemical entities for treating leishmaniasis. Sesquiterpene lactones are a recognized class of terpenoids with a wide spectrum of biological activities, including activity against Leishmania spp. In this work, a sesquiterpene lactone-rich preparation-a leaf rinse extract (LRE) from Tithonia diversifolia-was tested against promastigote forms of L. braziliensis. The results revealed that the LRE is a rich source of potent leishmanicidal compounds, with an LD50 value 1.5 ± 0.50 µg·mL-1. Therefore, eight sesquiterpene lactones from the LRE were initially investigated against promastigote forms of L. braziliensis. One of them did not present any significant leishmanicidal effect (LD50 > 50 µg·mL-1). Another had a cytotoxic effect against macrophages (4.5 µg·mL-1). The five leishmanicidal compounds with the highest level of selectivity were further evaluated against intracellular parasites (amastigotes) using peritoneal macrophages. Tirotundin 3-O-methyl ether, tagitinin F, and a guaianolide reduced the internalization of parasites after 48 h, in comparison with the negative control. This is the first report on sesquiterpene lactones that have potent leishmanicidal effects on both developmental stages of L. braziliensis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24830711 PMCID: PMC6271005 DOI: 10.3390/molecules19056070
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Scanning electron microscopy of untreated (A) and 10 µg/mL leaf rinse extract-treated (B) L. braziliensis promastigotes. Bar, 5 μm
Figure 2Chemical structures of sesquiterpene lactones isolated from the leaves of T. diversifolia.
In vitro antileishmanial activities of sesquiterpene lactones from T. diversifolia against L. braziliensis promastigotes and cytotoxic effects on peritoneal macrophages.
| Compounds | LD50 for
| LD50 for macrophages µg·mL−1 | Selectivity Index |
|---|---|---|---|
|
| 3.2 ± 0.5/9.2 ± 1.4 | 4.5 ± 0.9 | 1.4 |
|
| 2.2 ± 0.9/6.0 ± 2.5 | >50.0 | >22.7 |
|
| >50.0 | >50.0 | - |
|
| 8.7 ± 1.9/24.7 ± 5.4 | 24.9 ± 1.1 | 2.9 |
|
| 13.7 ± 2.6/37.4 ± 7.1 | >50.0 | >3.6 |
|
| 7.4 ± 2.8/21.2 ± 8.0 | >50.0 | >6.7 |
|
| 9.0 ± 1.2/24.6 ± 3.3 | >50.0 | >5.5 |
|
| 7.5 ± 3.2/20.4 ± 8.7 | >50.0 | >6.6 |
Figure 3Leishmanicidal activity of STL 2 and 5–8 against intracellular parasites. Infected peritoneal macrophages were treated with STL at LD50 concentration, previously determined as for promastigotes, for 48 h at 34 °C and 5% of CO2. Compounds 5, 6 and 7 showed statistically significant differences (T-test p values of 0.012, 0.035 and 0.018, respectively) when compared with control. The infection index was calculated by multiplying the percentage of infected macrophages by the average number of amastigotes per macrophage. Control corresponds to untreated infected peritoneal macrophages.